Physician profile
Jay Schon
NPI 1093556714
$960.70
in general payments reported to CMS, 2019-2025
9 companies · $583 in 2025
The $583 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $378 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $307.96 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Amgen INC. | $124.99 | 2024 | Krystexxa |
| Bioventus LLC | $124.79 | 2025 | Exogen Ultrasound Bone Healing System |
| Aroa Biosurgery Incorporated | $119.02 | 2025 | |
| Organogenesis INC. | $114.68 | 2024 | Affinity, Puraply Wound Matrix, Apligraf |
| Stryker Corporation | $77.11 | 2025 | Easyfuse, Augment Injectable, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $48.18 | 2025 | |
| Elite Orthopedics, LLC | $30.36 | 2025 | |
| Solventum Corporation | $13.61 | 2025 | V.A.C.Instill, Activ.A.C., Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Schon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.